Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain × Ralfinamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neuroma 1

Interventions

Fentanyl 21 Analgesia 20 Morphine 17 Acupuncture Therapy 17 Zoledronic Acid 13 Acetaminophen 13 Oxycodone 12 Ketamine 12 Therapeutics 11 Lidocaine 11 Radiotherapy 10 Methadone 10 Ibandronic Acid 10 Hydromorphone 10 nabiximols 9 Ropivacaine 8 Bupivacaine 8 Surveys and Questionnaires 7 Psychiatric Rehabilitation 6 Early Intervention, Educational 6 Water 5 Tapentadol 5 Pregabalin 5 Music Therapy 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Control Groups 5 Analgesics, Opioid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01019824 2017-09-15

Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

Newron Pharmaceuticals SPA

Phase 3 Completed

Neuroma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡